Tampolay, Leah .

HRN: 23-65-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/03/2023
09/09/2023
IV
4.5
Q6
Urosepsis
Waiting Final Action 
09/05/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/05/2023
09/12/2023
IVT
500mg
Q8
PID
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: